Evidence map›Paper›PMID 31249936›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2018

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort.

Inger Lise Gade, Sigrid K Brækkan, Inger Anne Næss, John-Bjarne Hansen, Suzanne C Cannegieter, Frits R Rosendaal, Kim Overvad, Kristian Hindberg, Jens Hammerstrøm, Olga V Gran and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Patients With MEN1 Are at an Increased Risk for Venous Thromboembolism.The Journal of clinical endocrinology and metabolism · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Inger Lise GadeDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Sigrid K BrækkanDepartment of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
Inger Anne NæssDepartment of Haematology, Trondheim University Hospital, Trondheim, Norway.
John-Bjarne HansenDepartment of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
Suzanne C CannegieterDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Frits R RosendaalDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Kim OvervadSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Kristian HindbergDepartment of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
Jens HammerstrømDepartment of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Olga V GranDepartment of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø-The Arctic University of Norway, Tromsø, Norway.
Anne TjønnelandDepartment of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Marianne T SeverinsenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Søren R KristensenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Aalborg University · DKAalborg University Hospital · DKLeiden University Medical Center · NLUiT The Arctic University of Norway · NOUniversity Hospital of North Norway · NODanish Cancer Society · DKNorwegian University of Science and Technology · NOSt Olav's University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10

Indexed as

cancerepidemiologyprospective studiestime factorsvenous thromboembolism

Identifiers

PMID31249936
PMCPMC6524868
OpenAlexW2795737179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.